First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 StudyShukui Qin, Shouguo Li, Hongming Pan et al.|Advances in Therapy|2025Cited by 9